Aurobindo Pharma informs about investor grievance report

10 Apr 2017 Evaluate

Pursuant to Regulation 13(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015, Aurobindo Pharma has informed about Investor Grievance Report for the Quarter ended 31.03.2017.

The above information is a part of company’s filings submitted to BSE.

Aurobindo Pharma Share Price

1087.10 -27.80 (-2.49%)
19-Apr-2024 16:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1525.00
Dr. Reddys Lab 5942.65
Cipla 1345.35
Zydus Lifesciences 925.95
Lupin 1547.05
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.